Robert Dehney News Today

Mallinckrodt Plc has defeated insurers' claims accusing the drugmaker of engaging in anticompetitive practices to inflate the price of one of its top products.

Mallinckrodt Plc filed for bankruptcy last year to resolve thousands of lawsuits accusing it of fueling the opioid epidemic, but as it aims to bring the process to a close, it must first address a completely different kind of claim.